Litigation
Lonza Group AG v. Northwest Biotherapeutics, Inc.
8:07-cv-03177
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Filed
- 2007-11-27
Patents at issue (8)
Plaintiffs (1)
Defendants (1)
Summary
Lonza Group AG sued Northwest Biotherapeutics, Inc. in the District of Maryland for patent infringement under 35 U.S.C. § 271, asserting U.S. 5,827,739 together with related gene-expression patents against NWBT's DCVax products. Lonza amended its complaint on December 13, 2007 to withdraw all infringement allegations relating to products other than DCVax-Prostate; no final disposition was confirmed in the narrative.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).